ATS GUIDELINES Bundle

Nontuberculous Myobacterial Pulmonary Disease

American Thoracic Society Quick-Reference GUIDELINES Apps

Issue link: https://eguideline.guidelinecentral.com/i/1279658

Contents of this Issue

Navigation

Page 11 of 13

12 Treatment Table 6. Common Adverse Drug Reactions and Monitoring Recommendations a Drug Adverse Reactions Monitoring Azithromycin/ clarithromycin Gastrointestinal Clinical monitoring Tinnitus/hearing loss Audiogram Hepatotoxicity Liver function tests Prolonged QTc ECG (QTc) Clofazimine Tanning of skin and dryness Clinical monitoring Hepatotoxicity Liver function tests Prolonged QTc ECG (QTc) Doxycycline GI upset Clinical monitoring Photosensitivity Clinical monitoring Tinnitus/vertigo Clinical monitoring Ethambutol Ocular toxicity Visual acuity and color discrimination Neuropathy Clinical monitoring Isoniazid Hepatitis Liver function tests Peripheral neuropathy Clinical monitoring Linezolid Peripheral neuropathy Clinical monitoring Optic neuritis Visual acuity and color discrimination Cytopenias Complete blood count Moxifloxacin Prolonged QTc ECG (QTc) Hepatotoxicity Liver function tests Tendinopathy Clinical monitoring Trimethoprim/ sulfamethoxazole GI upset Clinical monitoring Cytopenias Complete blood count Hypersensitivity Clinical monitoring Photosensitivity Clinical monitoring Rifabutin Uveitis Visual acuity

Articles in this issue

view archives of ATS GUIDELINES Bundle - Nontuberculous Myobacterial Pulmonary Disease